Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.

AUTOR(ES)

Mitchell, B S

RESUMO

Deoxyadenosine at low concentrations and in the presence of an inhibitor of adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) is markedly toxic to lymphoblast cell lines of T cell origin but does not impair growth of B cell lines. Deoxyguanosine is also more toxic for T lymphoblasts. In the presence of deoxyadenosine or deoxyguanosine, elevation of the corresponding deoxyribonucleoside triphosphate (dATP or dGTP) occurs in T cell, but not in B cell, lines. The addition of deoxycytidine or dipyridamole results in lower dATP and dGTP levels and prevents deoxyribonucleoside toxicity. These findings provide a molecular basis for the immunodeficiency observed in individuals with several inborn errors of purine metabolism.

Documentos Relacionados

• Purinogenic Immunodeficiency Diseases: DIFFERENTIAL EFFECTS OF DEOXYADENOSINE AND DEOXYGUANOSINE ON DNA SYNTHESIS IN HUMAN T LYMPHOBLASTS
• Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.
• Selective Toxicity of Diphtheria Toxin for Malignant Cells
• Selective Utilization of Pyrimidine Deoxyribonucleosides for Deoxyribonucleic Acid Synthesis in Pneumococcus
• Human immunodeficiency virus/acquired immunodeficiency syndrome and tropical diseases: a Brazilian perspective